RE: SP creeping back up1 Nov 2024 18:09
Dear all,
I am not a LTH but a a short- to mid term holder...I bought in at a bit too high a price so I am in red here....so I guess I share the fate of many LTHs in a way and can empathize with them!
I can understand frustration at Scancell communication but there is one or two things that I think one should point out and hold as a positive against Scancell:
1. Lindy is a highly respected scientist and she is super motivated here - for scientific reasons and humanitarian reasons and to a certain extent also financial reasons. Please compare this lady and her qualities to so many of the not overly bright, gabby, shallow, deceiving CEOs that seem to be in charge of small UK listed companies. I feel that I can trust her - full stop.
2. I am not an expert but what they are conducting is complicated science and like cutting-edge research obstacles appear and might take longer to be overcome - with Lindy and the Scancell team at the end still at the "mercy" of what the test results will show. However, I really believe that her excitement in communications is not fake but genuine so this leads me to think Scancell are on a good path.
3. Good/great scientists are not always good company leaders or capital markets savvy - so good we have two experienced biotech funds covering Lindy's and our backs...plus a new incoming CEO.
So all in all I keep the faith as I have faith in the intellectual calibre underpinning Scancell.
Now the only note of caution is that retail investors need to be watchful that their interests and those of the biotech funds don't diverge.....